Brain metastases in patients with differentiated thyroid carcinoma

Clinical Oncology

Volumn 8, Issue 5, 1996, Pages 327-330

  Hjiyiannakis, P ^a   Jefferies, S ^a   Harmer, C L ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

131Iodine dosimetry; Brain metastases; Thyroid carcinoma

Indexed keywords

IODINE 131;

ADOLESCENT; ADULT; ARTICLE; BRAIN METASTASIS; CANCER SURVIVAL; CLINICAL ARTICLE; DOSIMETRY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; THYROID CARCINOMA;

EID: 0029798928     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0936-6555(05)80722-8     Document Type: Article

References (18)

1. Harmer CL. Thyroid cancer. In: Horwich A, editor. Oncology: A multidisciplinary textbook. London: Chapman and Hall, 1995:565-84.
2. Harmer CL. Mulitdisciplinary management of thyroid neoplasms. In: Preece PE, Rosen RD, Maran AGD, editors. Head and neck oncology for the general surgeon. London: Saunders, 1991:55-90.
3. Tubiana M, Schlumbergen M, Rougier P, et al. Long term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer 1985;55:794-804.
4. Spiessl B, Beahrs OH, Hermanek P, et al. editors. TNM atlas. Berlin: Springer-Verlag. 1992:56-61.
5. Powell S, Harmer C. Thyroid cancer causing death after 40 years: Rationale for intensive treatment. Eur J Surg Oncol 1990;16:457-61.
6. O'Connell MEA. Treatment volume and radioactive dose-response in differentiated thyroid carcinoma [thesis]. London: University of London, 1992.
7. Flower MA, Hinton PJ, Adam I, et al. Practical implementation using quantitative scanning and PET with initial results on thyroid carcinoma. Radiother Oncol 1989;15:345-57.
8. O'Connell MEA, Flower MA, Hinton PJ, et al. Radiation dose assessment in radioactive therapy: Dose response relationships in differentiated thyroid carcinoma using quantitative scanning and PET. Radiother Oncol 1993;28:16-20.
9. Venkatesh S, Leavens ME, Samaan NA. Brain metastases in patients with well differentiated thyroid carcinoma: A study of 11 cases. Eur J Surg Oncol 1990;16:448-50.
10. McConahey WM, Hay ID, Woolner LB. Papillary thyroid cancer treated at the Mayo Clinic 1946 through to 1970: Initial manifestations, pathological findings, therapy, outcome. Mayo Clinic Proc 1986;61:978-96.
11. Brown AP, Greening WP, McCready VR, et al. Radioiodine treatment of metastatic thyroid carcinoma: the Royal Marsden Hospital experience. Br J Radiol 1984;57:323-7.
12. Black EG, Gimlette TMD, Maisey MN, et al. Serum thyroglobulin in thyroid cancer. Lancet 1981;ii:443-5.
13. Van Surge-Van Boxtell RAJ; Van Eck-Smit BLF, Goslings BM. Comparison of serum thyroglobulin, 131, and 201 T1 scintigraphy in the postoperative follow up of differentiated thyroid cancer. Nucl Med Commun 1993;14:365-72.
14. Maxon HR, Engaro EE, Thomas SR, et al. Radioiodine 131 therapy for well differentiated thyroid cancer: A quantitative radiation dosimetric approach: Outcome and validation in 85 patients. J nucl Med 1992;33:1132-6.
15. Harmer CL. External beam radiotherapy for thyroid cancer, Ann Radiol 1977;20:791-800.
16. Mundy J. Some investigations in relation to the immunoassay of human thyroglobulin [thesis]. Uxbridge: Brunel University, 1986.
17. Timothy J, Kerawala C, Brazil L, et al. Medullary cell carcinoma of the thyroid: Metastases to the central nervous system. Eur J Surg Oncol 1995;21:329-30.
18. Jyothirmayi R, Edison J, Nayer P, et al. Brain metastases from papillary carcinoma of the thyroid. Br J Radiol 1995;68:767-9.